Fibrinogen alpha chain O-glycopeptides as possible markers of urinary tract infection

Journal of Proteomics

Volumn 75, Issue 3, 2012, Pages 1067-1073

  Pacchiarotta, Tiziana ^a   Hensbergen, Paul J ^a   Wuhrer, Manfred ^a   Van Nieuwkoop, Cees ^a   Nevedomskaya, Ekaterina ^a   Derks, Rico J E ^a   Schoenmaker, Bart ^a   Koeleman, Carolien A M ^a   Van Dissel, Jaap ^a   Deelder, André M ^a   Mayboroda, Oleg A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

E. coli; Fibrinogen; Glycosylation; Mass spectrometry; Urinary tract infection

Indexed keywords

FIBRINOGEN; GLYCOPEPTIDE;

ADULT; AGED; ALPHA CHAIN; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; URINARY TRACT INFECTION;

ADULT; AGED; BIOLOGICAL MARKERS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FIBRINOGEN; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PEPTIDES; URINARY TRACT INFECTIONS;

EID: 84255178232     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.10.021     Document Type: Article

References (27)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(Suppl 1A):5S-13S.
2. Wilson M.L., Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004, 38:1150-1158.
3. Lee J.B.L., Neild G.H. Urinary tract infection. Medicine (Baltimore) 2007, 35:423-428.
4. Funfstuck R., Ott U., Naber K.G. The interaction of urinary tract infection and renal insufficiency. Int J Antimicrob Agents 2006, 28(Suppl 1):S72-S77.
5. Ferreira L., Sanchez-Juanes F., Gonzalez-Avila M., Cembrero-Fucinos D., Herrero-Hernandez A., Gonzalez-Buitrago J.M., et al. Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010, 48:2110-2115.
6. Seng P., Drancourt M., Gouriet F., La Scola B., Fournier P.E., Rolain J.M., et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009, 49:543-551.
7. Good D.M., Zurbig P., Argiles A., Bauer H.W., Behrens G., Coon J.J., et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010, 9:2424-2437.
8. Hiemstra H.S., Duinkerken G., Benckhuijsen W.E., Amons R., de Vries R.R., Roep B.O., et al. The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci U S A 1997, 94:10313-10318.
9. van der Starre W.E., van Nieuwkoop C., Paltansing S., van't Wout J.W., Groeneveld G.H., Becker M.J., et al. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother 2011, 66:650-656.
10. van Nieuwkoop C., Bonten T.N., Wout J.W., Becker M.J., Groeneveld G.H., Jansen C.L., et al. Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis 2010, 50:e69-e72.
11. van Nieuwkoop C., Bonten T.N., van't Wout J.W., Kuijper E.J., Groeneveld G.H., Becker M.J., et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 2010, 14:R206.
12. Wang J., Balog C.I., Stavenhagen K., Koeleman C.A., Scherer H.U., Selman M.H., et al. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol Cell Proteomics 2011, 10(M110):004655.
13. Nevedomskaya E., Derks R., Deelder A.M., Mayboroda O.A., Palmblad M. Alignment of capillary electrophoresis-mass spectrometry datasets using accurate mass information. Anal Bioanal Chem 2009, 395:2527-2533.
14. Smith C.A., Want E.J., O'Maille G., Abagyan R., Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006, 78:779-787.
15. Nilsson J., Ruetschi U., Halim A., Hesse C., Carlsohn E., Brinkmalm G., et al. Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods 2009, 6:809-811.
16. Wopereis S., Grunewald S., Morava E., Penzien J.M., Briones P., Garcia-Silva M.T., et al. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin Chem 2003, 49:1839-1845.
17. Vaith P., Assmann G., Uhlenbruck G. Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins. Biochim Biophys Acta 1978, 541:234-240.
18. Gornik O., Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers 2008, 25:267-278.
19. Fananapazir L., Eccleston M., Edmond E., Anderton J.L. Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illness. Lancet 1977, 1:933-935.
20. Kwaan H.C., Barlow G.H. Nature and biological activities of degradation products of fibrinogen and fibrin. Annu Rev Med 1973, 24:335-344.
21. Blainey J.D., Terry J.M. Urinary fibrinogen degradation products and differential protein clearances in renal disease. Clin Nephrol 1979, 11:140-141.
22. Metzger J., Kirsch T., Schiffer E., Ulger P., Mentes E., Brand K., et al. Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. Kidney Int 2010, 78:1252-1262.
23. Fu Y., Zhang J.Z., Redman C.M., Grieninger G. Formation of the human fibrinogen subclass fib420: disulfide bonds and glycosylation in its unique (alphaE chain) domains. Blood 1998, 92:3302-3308.
24. L'Hote C., Berger S., Karamanos Y. O-Glycosylation of fibrinogen from different mammalian species as revealed by the binding of Escherichia coli biotinylated lectins. Thromb Haemost 1996, 76:710-714.
25. Weisel J.W. Fibrinogen and fibrin. Adv Protein Chem 2005, 70:247-299.
26. Nossel H.L. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis. N Engl J Med 1976, 295:428-432.
27. Gramse M., Bingenheimer C., Schmidt W., Egbring R., Havemann K. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro. J Clin Invest 1978, 61:1027-1033.